Read more about TB-500 here
What to know: The FDAs Pharmacy Compounding Advisory Committee (PCAC) voted last week to recommend adding six popular peptides, including BPC-157, to the 503A bulk drug list, a decision that could expand access for American consumers if the FDA formally adopts the recommendation
After a 2-day treatment period, the cells were allowed to recover in fresh growth medium for 4 d before further experimentation
Anyone claiming that BPC-157 is a 'fat-burning peptide' is either misinformed or, frankly, being misleading
It is characterized by its ability to accelerate the healing of a huge variety of wounds such as skin, cornea, muscle, colon, bone defects and tendons
The prudent approach assumes additive effects are possible in either direction and warrants close monitoring of coagulation parameters